Mannatide Combined With CAPOX and Tislelizumab for Advanced Gastric Cancer.

NCT07655661 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Gastric Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma

Interventions

DRUG: Oxaliplatin
DRUG: Capecitabine
DRUG: Tislelizumab
DRUG: Mannatide

Sponsor

Ming Liu